Pulmonary Infections
Conditions
Interventions
None listed
Sponsors
Shigeru KOHNO
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Age: over 15 and under 49 years old (2) Location for treatment: outpatient (3) Patients with acute upper respiratory tract infection including acute bronchitis (Acute tonsilitis, acute Pharngitis) (4) Patient who has cough of strong persistent susceptibility, becomes insomnia at night (5) Patient who judged that the intensity of cough had not passed over a peak (6) After development of symptoms, the patient for less than three weeks (7) Patient who has a person of the same cough by the circumferences (8) Patient to whom expectoration can extract not pus-sputum but pharynx (9) Patients who do not agree to participate in this study
Exclusion criteria
Exclusion criteria: (1) Patients enrolled in entry of the study (2) Patients within 7days of CAM treatment (3) Patient who has condition in an improvement tendency by medication of other antimicrobial drugs (4) Patients whose diseases have taboo against the used antibiotics. (5) Patient with the patient or the past which has a chronic respiratory disease (6) Patient who has cough owing to foreign-body aspiration (7) Patient who has cough owing to gastroesophageal regurgitation (8) Patient who takes a medicine in an ACE inhibitor and has cough owing to it (9) Patient who has cough owing to it, cough asthma, atopic, the patient that has cough owing to allergic rhinitis (10) Patient who has cough owing to cardiac disease (11) Confirmed influenza virus infection. (12) Patient permitted the unusual shades, such as tuberculosis and a tumor, by the breast image inspection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of adverse event, Rate of bacterial eradication | — |
Countries
Japan
Contacts
Public ContactKoichi IZUMIKAWA
Nagasaki University Second department of internal medicine
Outcome results
None listed